Call Guidelines This Activity is addressed to highest quality or most promising research entities of significant size (such as University Departments, Faculties, specialised Research Institutes or important size research laboratories, with at least 10 permanent experienced researchers), established in the eligible regions. These research entities may be qualified in any S&T field within the scope of EU FP7. In the proposals, the applicants have to provide evidence of their excellence in research and of their leadership potential in the scientific fields of their competence. They should include a clear description of their RTD objectives, their main research activities and demonstrate a good track-record of achievements; self-assess their research accomplishments to demonstrate their potential and expertise; describe the organisation of their entity (who is doing what, short description of available research facilities in terms of staff and durable equipment); provide short CVs of the most important researchers of their entity, a list of most recent and significant publications or patents, collaborations with other RTD entities in the country or elsewhere, potential participation in research programmes or activities funded by the European Union, other national or international organisations or the private sector (SMEs, industry, end-users), etc.
InnoMol – what is it? Biology Medicine Chemistry Synergy
InnoMol network 11 EU members 1 Associated state 36 Partners
INNOMOL – Action plan Four coherent measures Twinning through exchange of know-how and experience Recruitment of experienced researchers Upgrading, development or acquisition of research equipment Innovation capacity building
I NNO M OL – goals Fostering a research pipeline at the Ruđer Bošković Institute and facilitating new avenues of innovation and technology for the investigation of relevant diseases Assemble critical mass of resources and expertises Bring together and reinforce 3 major worlds of life sciences, e.g. Medicine, Biology, and Chemistry to create a productive, state-of-the- art environment that is unique in the region Recruitment – reducing the brain drain Ultimative goal of the project is to find new molecular solutions and new drugs for therapeutic use.
I NNO M OL – implementation Organization of work in workpackages (WP) 7 WP
Workpackage leaders Maja Herak Bosnar – Recruitment (WP1) Marijeta Kralj – Exchange & Secondment (WP2) Ivo Piantanida – Equipment Implementation & Exploitation (WP3) Marin Roje – IPR Management (WP4) Ivanka Jerić – Dissemination & Visibility Activities (WP5) David Smith – Management (WP6) Miroslav Plohl – Ex-Post Evaluation (WP7)
+ 3 technicians & 1 administrator The goal is to hire 7 experienced researchers, to transfer their knowledge and research skills to actual and new staff, and subsequently, to upgrade recruited researchers through secondments and exchange with partnering organizations to become excellent in respective field of expertise. Focus on returning nationals Managerial skills Enhance research capacities and capabilities of applicant by hiring new researchers. Appropriate gender balance WP 1 - Recruitment
WP3 - Equipment 2.5 mil EUR Available equipmnet 1.4 mil EUR EC contribution
WP4 – IPR Management Objectives to develop the plan for IP management to integrate InnoMol scientific output to the knowledge database of RBI Recruitment - 1 IP manager
WP5 - Dissemination Only active participation at the conferences/workshops/seminars/Round Tables will be supported. Active participation includes lecture or poster with the most recent research results or chairmanship of conference/workshop or session.
WP5 - Dissemination Co-organise 13th Multinational Congress on Microscopy, 2015. Epigenomics Congress – International, 2016
WP5 - Dissemination Staff from RBI will engage in technical organization of 5 workshops (M9, 14, 18, 22, 35) Lectures for Workshops of secondees from partnering organizations
WP7- Ex-Post Evaluation The main task of this WP is to apply for an international independent expert evaluation of overall RBI research quality and capability (including management and infrastructure). The evaluation will take place at the end of the implementation of the Action Plan.
Period: 2014-2020 Budget: 71 billion (FP7 55 billion) The Horizon 2020 programme consists of the following parts: – “Excellent science” (24 598 million EUR) – “Industrial leadership” (17 938 million EUR) – “Societal challenges” (31 748 million EUR) – In addition, there is a specific programme named „Non-nuclear direct actions of the Joint Research Centre (JRC)” (1962 million EUR). – http://www.eutrainingsite.com/2014-2020.php?id=106#euf http://www.eutrainingsite.com/2014-2020.php?id=106#euf